AlloVir Stock (NASDAQ: ALVR) stock price, news, charts, stock research, profile.
Open | $0.780 |
Close | - |
Volume / Avg. | 8.397K / 730.115K |
Day Range | 0.770 - 0.781 |
52 Wk Range | 0.623 - 6.120 |
Market Cap | $88.483M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 10.19% |
Days to Cover | 11.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AlloVir (NASDAQ: ALVR) through any online brokerage.
Other companies in AlloVir’s space includes: Anixa Biosciences (NASDAQ:ANIX), Curis (NASDAQ:CRIS), Cellectar Biosciences (NASDAQ:CLRB), Burning Rock Biotech (NASDAQ:BNR) and FibroGen (NASDAQ:FGEN).
The latest price target for AlloVir (NASDAQ: ALVR) was reported by B of A Securities on Tuesday, December 26, 2023. The analyst firm set a price target for 1.00 expecting ALVR to rise to within 12 months (a possible 28.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for AlloVir (NASDAQ: ALVR) is $0.78128 last updated Today at April 26, 2024 at 10:14 AM EDT.
There are no upcoming dividends for AlloVir.
AlloVir’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for AlloVir.
AlloVir is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.